-Reuters
Related Posts
Avidity Biosciences Partners with Bristol Myers Squibb in $2.3B Deal for Cardiovascular RNA Therapeutics, Secures $100M Upfront
Avidity Biosciences, Inc. (NASDAQ:RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs), today announced a global licensing and
Why Sleep Disorder Focused Vivos Therapeutics Stock Trading Higher Today?
Vivos Therapeutics Inc (NASDAQ: VVOS) announced two critical strategic agreements that will expand Vivos' current product line and are expected to create near-term
Black Hills Sees FY23 Guidance $3.65-$3.85 Vs $3.75 Est.;
2023 EARNINGS GUIDANCE REAFFIRMED
Black Hills affirms its guidance for 2023 earnings per share available for common stock to be in the range of $3.65 to $3.85 based on the follow